Connection
John Messenger to Hospitals
This is a "connection" page, showing publications John Messenger has written about Hospitals.
|
|
Connection Strength |
|
|
|
|
|
0.699 |
|
|
|
-
Castro-Dominguez YS, Curtis JP, Masoudi FA, Wang Y, Messenger JC, Desai NR, Slattery LE, Dehmer GJ, Minges KE. Hospital Characteristics and Early Enrollment Trends in the American College of Cardiology Voluntary Public Reporting Program. JAMA Netw Open. 2022 02 01; 5(2):e2147903.
Score: 0.144
-
Vora AN, Peterson ED, McCoy LA, Garratt KN, Kutcher MA, Marso SP, Roe MT, Messenger JC, Rao SV. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv. 2016 Apr 25; 9(8):771-779.
Score: 0.096
-
Sherwood MW, Brennan JM, Ho KK, Masoudi FA, Messenger JC, Weaver WD, Dai D, Peterson ED. The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings. JACC Cardiovasc Interv. 2015 Jan; 8(1 Pt A):10-6.
Score: 0.088
-
Bradley SM, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, Rumsfeld JS, Gurm HS. Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2014 Jul; 7(4):550-9.
Score: 0.085
-
Cram P, House JA, Messenger JC, Piana RN, Horwitz PA, Spertus JA. Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR?. Am Heart J. 2012 Feb; 163(2):214-21.e1.
Score: 0.072
-
Cram P, House JA, Messenger JC, Piana RN, Horwitz PA, Spertus JA. Percutaneous coronary intervention outcomes in US hospitals with varying structural characteristics: analysis of the NCDR?. Am Heart J. 2012 Feb; 163(2):222-9.e1.
Score: 0.072
-
Douglas PS, Patel MR, Bailey SR, Dai D, Kaltenbach L, Brindis RG, Messenger J, Peterson ED. Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. J Am Coll Cardiol. 2011 Aug 16; 58(8):801-9.
Score: 0.070
-
Chau KH, Kennedy KF, Messenger JC, Garratt KN, Maddox TM, Yeh RW, Kirtane AJ. Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project. JAMA Cardiol. 2019 06 01; 4(6):564-568.
Score: 0.030
-
Sandhu A, McCoy LA, Negi SI, Hameed I, Atri P, Al'Aref SJ, Curtis J, McNulty E, Anderson HV, Shroff A, Menegus M, Swaminathan RV, Gurm H, Messenger J, Wang T, Bradley SM. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circulation. 2015 Sep 29; 132(13):1243-51.
Score: 0.023
-
Wang TY, McCoy LA, Messenger JC, Neely ML, Ho KK, Roe MT, Anderson HV. Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry. Am Heart J. 2013 Nov; 166(5):927-34.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|